Regulatory Affairs Outsourcing Market Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-2027

1
Global Regulatory Affairs Outsourcing Market
Research and Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Regulatory Affairs Outsourcing Market
Research Report 2022-2027 The latest report by
IMARC, titled Regulatory Affairs Outsourcing
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2022-2027,
finds that the global regulatory affairs market
size reached US 6.43 Billion in 2021.
Regulatory affairs outsourcing refers to the
hiring process of third-party services by private
organizations and government bodies in order to
ensure public health and safety. These services
include managing regulatory requirements for
innovator drugs, generic drugs, biosimilars,
biologics, and others. Outsourcing organizations
ensure the safety and efficacy of the products
while ensuring they are safe for consumption.
These services are used for regulatory writing
and publishing, clinical trial and patent
application, legal representation, and product
registration. In recent years, regulatory affairs
outsourcing has gained momentum due to its
adoption in pharmaceutical companies for
achieving speedy government approvals. We are
regularly tracking the direct effect of COVID-19
on the market, along with the indirect influence
of the associated industries. These observations
will be further integrated into the
report. Request for a PDF sample of this report
https//www.imarcgroup.com/regulatory-affairs-out
sourcing-market/requestsample

4
Report Description and Highlights
Report Description

Global Regulatory Affairs Outsourcing Market
Trends One of the primary factors driving the
market is the exponential growth in the
biotechnological and pharmaceutical industries.
Additionally, the increasing focus of
pharmaceutical industries on expanding their
supplies and operations in developing economies
is creating a positive market outlook. Other than
this, regulatory affairs outsourcing services are
employed to produce orphan, biosimilar, and
generic drugs. Besides this, these services
reduce the costs of managing in-house resources,
including training, facilities, technology,
specialized knowledge, and geographic
regulations. This, along with the increasing
number of trials, is boosting the demand for
regulatory affairs outsourcing. Furthermore,
extensive research and development (RD)
activities, improvements in the healthcare
industry, and a rise in the number of
FDA-approved manufacturing plants are catalyzing
the market growth. Looking forward, IMARC Group
expects the market size to reach US 10.76
Billion by 2017, expanding at a CAGR of 8.88
during the forecast period (2022-2027). View
Report TOC, Figures and Tables
https//www.imarcgroup.com/regulatory-affairs-outs
ourcing-market
5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Services
• Regulatory Consulting
• Legal Representation
• Regulatory Writing and Publishing
• Product Registration and Clinical Trial
  Applications
• Others
• Breakup by Company Size
• Small
• Medium
• Large
• Breakup by Stage
• Preclinical
• Clinical
• PMA (Post Market Authorization)

6
Report Description and Highlights
Report Description

•  
• Breakup by Category
• Generic Drugs
• Innovator Drugs
• Biologic Drugs
• Biosimilars
• Medical Devices
• Therapeutic
• Diagnostic
• Others
• Breakup by Indication
• Oncology
• Neurology
• Cardiology
• Immunology
• Others
• Breakup by End User

7
Report Description and Highlights
Report Description

•  
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
• Competitive Landscape
• Charles River Laboratories International Inc.
• Covance Inc (Laboratory Corporation of America
  Holdings)
• Freyr
• ICON Plc
• Medpace Holdings Inc.
• Parexel International Corporation
• Pharmaceutical Product Development LLC
• Promedica International- A California Corporation
• Wuxi AppTec Co.Ltd.

8
Key Questions Answered in the Report
Report Description

1. How has the global regulatory affairs outsourcing
   market performed so far and how will it perform
   in the coming years?
2. What has been the impact of COVID-19 on the
   global regulatory affairs outsourcing market?
3. What are the key regional markets?
4. What is the breakup of the market based on the
   services?
5. What is the breakup of the market based on the
   company size?
6. What is the breakup of the market based on the
   category?
7. What is the breakup of the market based on the
   indication?
8. What is the breakup of the market based on the
   stage?
9. What is the breakup of the market based on the
   end user?
10. What are the various stages in the value chain of
    the industry?
11. What are the key driving factors and challenges
    in the industry?
12. What is the structure of the global regulatory
    affairs outsourcing market and who are the key
    players?
13. What is the degree of competition in the industry?

9
Table of Contents
Report Description

1 Preface 2 Scope and Methodology 2.1
Objectives of the Study 2.2 Stakeholders
2.3 Data Sources 2.3.1 Primary
Sources 2.3.2 Secondary Sources 2.4
Market Estimation 2.4.1 Bottom-Up
Approach 2.4.2 Top-Down Approach
2.5 Forecasting Methodology 3 Executive
Summary 4 Introduction 4.1 Overview
4.2 Key Industry Trends 5 Global Regulatory
Affairs Outsourcing Market 5.1 Market
Overview 5.2 Market Performance 5.3
Impact of COVID-19 5.4 Market Forecast
10
Table of Contents
Report Description
6 Market Breakup by Services 6.1
Regulatory Consulting 6.1.1 Market
Trends 6.1.2 Market Forecast 6.2
Legal Representation 6.2.1 Market Trends
6.2.2 Market Forecast 6.3 Regulatory
Writing and Publishing 6.3.1 Market
Trends 6.3.2 Market Forecast 6.4
Product Registration and Clinical Trial
Applications 6.4.1 Market Trends
6.4.2 Market Forecast 6.5 Others
6.5.1 Market Trends 6.5.2 Market
Forecast Click here to visit the complete table
of content with list of figures and tables
https//www.imarcgroup.com/regulatory-affairs-out
sourcing-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us